This inventor holds 1 USPTO granted patent. Top assignee: Repare Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Stéphanie Lanoix: Innovator in Pharmaceutical Chemistry
Introduction
Stéphanie Lanoix is a notable inventor based in Mansfield, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. His work focuses on creating effective treatments for various health conditions.
Latest Patents
Stéphanie Lanoix holds 1 patent for his invention titled "Substituted 2-morpholinopyridine derivatives as ATR kinase inhibitors." This patent discloses compounds and pharmaceutically acceptable salts that may be utilized in treating subjects in need. The compounds are designed to inhibit Ataxia-telangiectasia and RAD-3-related protein kinase (ATR), offering potential therapeutic benefits. Additionally, the patent includes pharmaceutical compositions containing these compounds and methods for their preparation and use.
Career Highlights
Stéphanie Lanoix is currently associated with Repare Therapeutics Inc., where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative solutions in the pharmaceutical industry.
Collaborations
Stéphanie collaborates with Vouy-Linh Truong, contributing to the advancement of their shared goals in pharmaceutical research.
Conclusion
Stéphanie Lanoix is a dedicated inventor whose work in pharmaceutical chemistry has the potential to impact medical treatments significantly. His innovative approach to developing ATR kinase inhibitors showcases his commitment to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile